Foresite Capital Management II’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $29.2M | Hold |
708,528
| – | – | 100% | 1 |
|
|
2023
Q2 | $39.6M | Hold |
708,528
| – | – | 100% | 1 |
|
|
2023
Q1 | $39.5M | Sell |
708,528
-650,000
| -48% | -$36.3M | 100% | 1 |
|
|
2022
Q4 | $49.5M | Sell |
1,358,528
-395,000
| -23% | -$14.4M | 100% | 1 |
|
|
2022
Q3 | $49.9M | Hold |
1,753,528
| – | – | 100% | 1 |
|
|
2022
Q2 | $79.3M | Hold |
1,753,528
| – | – | 100% | 1 |
|
|
2022
Q1 | $133M | Hold |
1,753,528
| – | – | 100% | 1 |
|
|
2021
Q4 | $261M | Hold |
1,753,528
| – | – | 99.34% | 1 |
|
|
2021
Q3 | $255M | Hold |
1,753,528
| – | – | 90.72% | 1 |
|
|
2021
Q2 | $343M | Sell |
1,753,528
-500,000
| -22% | -$97.9M | 92.37% | 1 |
|
|
2021
Q1 | $408M | Sell |
2,253,528
-250,000
| -10% | -$45.3M | 93.76% | 1 |
|
|
2020
Q4 | $355M | Sell |
2,503,528
-1,000,000
| -29% | -$142M | 93.6% | 1 |
|
|
2020
Q3 | $437M | Sell |
3,503,528
-2,000,000
| -36% | -$249M | 95.05% | 1 |
|
|
2020
Q2 | $492M | Sell |
5,503,528
-1,083,725
| -16% | -$96.8M | 96.63% | 1 |
|
|
2020
Q1 | $411M | Sell |
6,587,253
-250,000
| -4% | -$15.6M | 95.85% | 1 |
|
|
2019
Q4 | $521M | Hold |
6,837,253
| – | – | 85.84% | 1 |
|
|
2019
Q3 | $345M | Buy |
+6,837,253
| New | +$345M | 72.85% | 1 |
|